Unità Operativa di Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino di Genova
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bennicelli, Elisa
MIRAGE, NCT06275919: Regorafenib for Recurrent Grade 2 and 3 Meningioma ( Trial)

Recruiting
2
104
Europe
Regorafenib 40 MG Oral Tablet, Local Standard of Care
Istituto Oncologico Veneto IRCCS, Bayer
Meningioma, Malignant
12/26
03/27
SILMET, NCT05689619: SILibinin in NSCLC and BC Patients With Single Brain METastasis

Recruiting
N/A
70
Europe
Silibinin, Sillbrain, Placebo
Azienda Ospedaliera Città della Salute e della Scienza di Torino
Brain Metastases, Adult, Non Small Cell Lung Cancer, Breast Cancer
09/25
09/27
RATIONAL, NCT05918666: National Register of Actionable Mutations

Recruiting
N/A
3000
Europe
Federation of Italian Cooperative Oncology Groups, Roche Pharma AG, AstraZeneca, Bayer, Bristol-Myers Squibb, Janssen, LP, Takeda, Amgen, Daiichi Sankyo, Inc., Eli Lilly and Company, Novartis, Clinical Research Technology S.r.l.
Solid Tumours in Advanced Stages
10/26
10/26

Download Options